Imidazolinone-tolerant crops: history, current status and future

Imidazolinone herbicides, which include imazapyr, imazapic, imazethapyr, imazamox, imazamethabenz and imazaquin, control weeds by inhibiting the enzyme acetohydroxyacid synthase (AHAS), also called acetolactate synthase (ALS). AHAS is a critical enzyme for the biosynthesis of branched-chain amino acids in plants. Several variant AHAS genes conferring imidazolinone tolerance were discovered in plants through mutagenesis and selection, and were used to create imidazolinone-tolerant maize (Zea mays L), wheat (Triticum aestivum L), rice (Oryza sativa L), oilseed rape (Brassica napus L) and sunflower (Helianthus annuus L). These crops were developed using conventional breeding methods and commercialized as Clearfield* crops from 1992 to the present. Imidazolinone herbicides control a broad spectrum of grass and broadleaf weeds in imidazolinone-tolerant crops, including weeds that are closely related to the crop itself and some key parasitic weeds. Imidazolinone-tolerant crops may also prevent rotational crop injury and injury caused by interaction between AHAS-inhibiting herbicides and insecticides. A single target-site mutation in the AHAS gene may confer tolerance to AHAS-inhibiting herbicides, so that it is technically possible to develop the imidazolinone-tolerance trait in many crops. Activities are currently directed toward the continued improvement of imidazolinone tolerance and development of new Clearfield* crops. Management of herbicide-resistant weeds and gene flow from crops to weeds are issues that must be considered with the development of any herbicide-resistant crop. Thus extensive stewardship programs have been developed to address these issues for Clearfield* crops.     

THE OESTROUS CYCLE OF THE MARE AND ITS UTERINE CONTROL

SUMMARY The reproductive findings from a group of nonpregnant mares were studied. Oestrous cycle length averaged 20.6 days (range 13–34) excluding anoestrous periods, or 25 days (31–141) if included. Average oestrus length was 5.7 days (range 1–24) but from February to May it averaged 7.6 days (range 2–24) and from May to November 4.8 days (range 1–10). Seventy-eight per cent of the mares ovulated within 48 hours prior to the end of oestrus, 10% were out of oestrus before ovulation occurred, while 76% of the ovulations occurred between 4 p.m. and 8 a.m. Follicles averaged 45 mm in size the day of ovulation and multiple ovulations occurred 25.5% of the time. Oestrus without associated ovulation was very uncommon in this group of mares, whereas ovulation without oestrus occurred in 6 of the 11 mares, including one mare who ovulated 32 of 34 times without oestrus. The CL were palpable for an average period of 8.9 days (range 1–18). On occasions, a hematoma formed within the ovulation site, reached a size of 10–12 cm in length and persisted beyond the next ovulation without affecting cycle length. Dioestrus averaged 15.4 days (range 6–25) excluding anoestrus, or 19.5 days (range 6–121) if anoestrus was included. Dioestrous ovulations unaccompanied by signs of oestrus and with the cervix pale, tight, dry and sticky occurred in 10 of the 11 mares. The CL formed following dioestrous ovuations were normal, but did not affect cycle length. A syndrome of spontaneous prolongation of the corpus luteum for 2 to 3 months was observed in 6 of the 11 mares. Oestrus was not manifested during this time, but considerable follicular activity and, in some instances, ovulation was observed. Hysterectomised mares and some mares with pyometra had prolonged CL and follicular activity with a few ovulating similar to mares with spontaneously-prolonged CL. Other mares with pyometra had normal cyclic ovarian activity. Evidence suggests that the endometrium had been destroyed by the infection in the anoestrus mares with pyometra and, thus, was incapable of forming and/or releasing luteolytic factors. Experimental intrauterine inoculation of Streptococcus zooepidemicus during dioestrus reduced oestrous cycle length in 5 of 7 inoculations, whereas inoculations during oestrus failed to alter cycle length.     

Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle

The efficacy of tulathromycin in the treatment (phase 1) and prevention (phase 2) of bovine respiratory disease (BRD) was evaluated on commercial farms in France, Germany, Italy, and Spain. In phase 1, commingled cattle with clinical BRD were treated with tulathromycin (n = 128) or florfenicol (n = 125) on day 0. Similar percentages of animals showed sustained clinical improvement at day 14 (tulathromycin 83.3% versus florfenicol 81.0%) and had not relapsed by day 60 (tulathromycin 63.3% versus florfenicol 58.4%). In phase 2, healthy in-contact cattle were treated with tulathromycin (n = 492), tilmicosin (n = 494), or saline (n = 265) on day 0. Significantly more (P = .0001) tulathromycin-treated cattle remained healthy to day 14 (92.4%) than tilmicosin-treated (83.7%) or saline-treated (63.7%) cattle, and this was maintained through day 60 (tulathromycin 85.4% versus tilmicosin 75.1% and saline 56.2%). Tulathromycin was highly effective in the treatment and prevention of BRD.